|
Match
|
Document |
Document Title |
|
|
7553497 |
Gelatin hard capsule enhancing the film strength
A process for preparing gelatin hard capsule having enhanced film strength by the steps including i) adding 1˜10 wt part of PEG mixture of PEG 600 and PEG 1500 in weight ratio 40˜60:60˜40 to the...
|
|
|
7544370 |
Pantoprazole multiparticulate formulations
Pantoprazole sodium multiparticulates are described which avoid sticking to nasogastric and gastronomy tubes. The pantoprazole multiparticulates have a spheroid core of pantoprazole or an...
|
|
|
7541422 |
Enzyme-catalyzed process for the preparation of macrocyclic polyester oligomers
A process for the enzyme-catalyzed preparation of cyclic ester oligomers from dicarboxylic acids and/or dicarboxylic acid derivatives and diols, hydroxycarboxylic acids and/or hydroxycarboxylic...
|
|
|
7510727 |
Melt-extrusion multiparticulates
A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an...
|
|
|
7485323 |
Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
The present invention provides a process to make a gelatine hydrolysate, a gelatine hydrolysate and gelatine compositions comprising gelatine hydrolysates. More specifically, the invention provides...
|
|
|
7452552 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7445796 |
Pharmaceutically active particles of a monomodal particle size distribution and method
A method of obtaining improved reproducibility of dissolution profiles of dosage forms containing pharmaceutically active particles includes steps of screening raw pharmaceutically active particles...
|
|
|
7445795 |
Delivery device, method of using and method of manufacturing
An active principle delivery device ( 1 ) comprising an inner capsule ( 4 ) within an outer capsule ( 2 ), the inner and outer capsules ( 4,2 ) containing the same active principle ( 5,3 ), with at...
|
|
|
7431941 |
Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil, olive...
|
|
|
7419687 |
Delivery vehicle for silver ions
A delivery vehicle for a silver ion source such as silver nitrate and the like, suitable for use in the treatment of menorrhagia, comprises a plurality of physiologically inert beads bearing a...
|
|
|
7417022 |
Compounds and compositions for delivering active agents
Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7393437 |
Photochemically crosslinked collagen scaffolds and methods for their preparation
A method for producing collagen-based scaffolds with improved characteristics, which broadens the usage of collagen in tissue engineering and the products so produced are described. The method...
|
|
|
7338943 |
Hyaluronic acid in soft gel form
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
|
|
|
7309499 |
Fish gelatin hard capsule and its preparation method
The object of the present invention is to provide a process for preparing fish gelatin capsule comprising the steps of; i) preparing a mixed solution of pectin and glycerin; ii) adding said mixed...
|
|
|
7273622 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7270831 |
Orally administrable opioid formulations having extended duration of effect
Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for...
|
|
|
7264824 |
Oral dosage form
Oral dosage form for food and food supplement as well as dietetics comprising polyunsaturated acids in a xylose-hardened gelatine capsule with a retarded release time.
|
|
|
7229639 |
Ibuprofen containing hard shell capsules
The present invention relates to pharmaceutically acceptable and stable compositions, which are preferably clear transparent, for liquid filling hard shell capsules, hard shell capsules containing...
|
|
|
7226613 |
Seamless filled capsules
Spherical capsule having a liquid core and a seamless solid shell surrounding the core, in which: the diameter of the capsule is in the range of 4-8 mm; the thickness of the shell is in the range...
|
|
|
7211274 |
Hair growth formulation
The present invention relates to a formulation for promoting hair growth and preventing hair loss. Supplementation with the formulation promotes hair growth and increases the number of hairs in...
|
|
|
7201921 |
Antihistamine formulations for soft capsule dosage forms
The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition...
|
|
|
7189412 |
Fenofibrate-containing composition
A novel fenofibrate-containing composition having equivalent bioavailability, when compared to conventional capsules, is effective in reducing the size of the conventional capsule preparations. The...
|
|
|
7182958 |
β-carboline pharmaceutical compositions
Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use...
|
|
|
7179791 |
Inhibiting GS-FDH to modulate NO bioactivity
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of...
|
|
|
7166299 |
Preparation of aqueous clear solution dosage forms with bile acids
Compositions for pharmaceutical and other uses comprising clear aqueous solutions of bile acids which do not form any detectable precipitates over selected ranges of pH values of the aqueous...
|
|
|
7163699 |
Progestin co-micronized with a surfactant pharmaceutical composition comprising same methods for making same and uses thereof
The invention concerns a progestin co-micronized with a surfactant and a pharmaceutical composition comprising said gestagenic. The invention also concerns methods for preparing same.
|
|
|
7141593 |
Pharmaceutical formulations
Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds having improved solubility properties in a medium and/or long chain fatty...
|
|
|
7112609 |
Nutritional supplements
The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved...
|
|
|
7101574 |
Pharmaceutical composition containing fenofibrate and the preparation method
The invention concerns a pharmaceutical composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative, as solubilizing adjuvant, preferably...
|
|
|
7094427 |
Combination immediate release controlled release levodopa/carbidopa dosage forms
The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated...
|
|
|
7094426 |
Stable oral pharmaceutical dosage forms
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
7087770 |
Compound containing a labile disulfide bond
A labile disulfide-containing compound under physiological conditions containing a labile disulfide bond and a transduction signal.
|
|
|
7087242 |
Subcoated simulated capsule-like medicament
A simulated capsule-like medicament comprising a subcoating of a mixture of a water-soluble, film-forming polymer, e.g. hydroxypropylmethyl cellulose and a hydrophobic plasticizer, e.g. castor oil,...
|
|
|
7078054 |
Soft gelatin capsule manufacture
Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a...
|
|
|
7074390 |
Encapsulated dentifrice and method of use
A single use capsule containing dentifrice is disclosed. It includes toothpaste or other dentifrice enclosed in a shell or coating. The dentifrice may include miswak fibers, which acts as a natural...
|
|
|
7070802 |
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7070800 |
Inhalable powder containing tiotropium
The invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them as well as their use in preparing a pharmaceutical composition for the treatment of...
|
|
|
7060263 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7041316 |
Stable oral pharmaceutical dosage forms
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
7029698 |
Acetaminophen compositions
The invention herein provides for an oral pharmaceutical composition adapted for use in capsular dosage forms comprising acetaminophen and a lactate salt alone or in combination with an acetate...
|
|
|
7014865 |
Natural formulation for the treatment and prevention of depression, containing St. John's Wort and derivatives of dihydro- and tetrahydrofolic acid
The present invention relates to novel compositions containing a combination of the plant St. John's Wort ( Hypericum perforatum L.), its extracts of active ingredients and derivatives of dihydro-...
|
|
|
7014864 |
Formulations comprising lipid-regulating agents
The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one structured lipid as the primary solvent medium for said agent. One or more...
|
|
|
7011968 |
Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
The invention relates to a synthetic, biologically active molecule for fixing an active ingredient to the virus protein 1 (VP1) of the polyoma virus. According to the invention, an amino acid...
|
|
|
7008639 |
Fish gelatin compositions containing a hydrocolloid setting system
The invention concerns Gelatin compositions for the use in pharmaceutical, veterinary, food, cosmetic or other products like films for wrapping food, aspics or jellies, preferably for predosed...
|
|
|
6979462 |
Stabilization of solid drug formulations
Pharmaceutical formulations and dosage forms are provided having improved stability to moisture-induced degradation when compared with conventional dosage forms, especially tablets. The invention...
|
|
|
6955820 |
Coenzyme Q10 formulation and process methodology for softgel capsules manufacturing
A formulation of Coenzyme Q 10 , beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a...
|
|
|
6951655 |
Pro-micelle pharmaceutical compositions
The present invention provides pro-micelle compositions comprising a pharmaceutically active agent encapsulated with a membrane of esterified C 12 -C 18 fatty acids. In the mammalian intestine,...
|
|
|
6929803 |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
A dosage form comprising a gelatin capsule formed with a composite wall and containing a liquid, active agent formulation where the wall comprises a barrier layer formed over the external surface...
|
|
|
6926938 |
Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film
The present invention provides a process for preparing hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film having good film distribution in capsule...
|
|
|
6926906 |
Orally administrable pharmaceutical formulation
The present invention relates to a pharmaceutical formulation for oral administration through a soft gelatin capsule drug delivery device, wherein the pharmaceutical formulation has Pseudoephedrine...
|